Eagle Asset Management Inc Nevro Corp Transaction History

Eagle Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$101.99 - $166.36 $25.4 Million - $41.5 Million	-249,468 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$141.6 - $179.06 $3.95 Million - $5 Million	-27,925 Reduced 10.07%	249,468 $41.4 Million
Q1 2021 May 14, 2021	BUY	$132.81 - $182.18 $1.51 Million - $2.07 Million	11,371 Added 4.27%	277,393 $39.4 Million
Q4 2020 Feb 12, 2021	BUY	$138.17 - $184.34 $8.87 Million - $11.8 Million	64,197 Added 31.81%	266,022 $46 Million
Q3 2020 Nov 12, 2020	BUY	$114.09 - $145.51 $2.45 Million - $3.12 Million	21,468 Added 11.9%	201,825 $28 Million
Q2 2020 Aug 12, 2020	BUY	$89.45 - $129.85 $16.1 Million - $23.4 Million	180,357 New	180,357 $21.3 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.